Send to

Choose Destination
Int J Cancer. 2018 Jan 1;142(1):44-56. doi: 10.1002/ijc.31043. Epub 2017 Oct 10.

Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.

Author information

Screening Group, International Agency for Research on Cancer, Lyon, France.
CPO Piemonte and University Hospital "Città della Salute e della Scienza", Turin, Italy.
Mass Screening Registry/Finnish Cancer Registry, Helsinki, Finland.
Departamento de Tocoginecologia, Divisão de Oncologia, Universidade Estadual de Campinas, Brazil.
Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Swedish Cervical Screening Registry, Stockholm, Sweden.
Regionalt cancercentrum Stockholm-Gotland, Stockholm, Sweden.
Cancer Registry of Norway, Oslo, Norway; Finnish Cancer Registry, Helsinki, Finland.

Erratum in


The second report on the implementation status of cancer screening in European Union (EU) was published in 2017. The report described the implementation status, protocols and organization (updated till 2016) and invitation coverage (for index year 2013) of breast, cervical and colorectal cancer screening in the EU. Experts in screening programme monitoring (N = 80) from the EU Member States having access to requisite information in their respective countries provided data on breast, cervical and colorectal cancer screening through online questionnaires. Data was collected for screening performed in the framework of publicly mandated programmes only. Filled in questionnaires were received from 26 Member States for all three sites and from one Member State for breast cancer only. Substantial improvement in screening implementation using population-based approach was documented. Among the age-eligible women, 94.7% were residents of Member States implementing or planning population-based breast cancer screening in 2016, compared to 91.6% in 2007. The corresponding figures for cervical cancer screening were 72.3 and 51.3% in 2016 and 2007, respectively. Most significant improvement was documented for colorectal cancer screening with roll-out ongoing or completed in 17 Member States in 2016, compared to only five in 2007. So the access to population-based screening increased to 72.4% of the age-eligible populations in 2016 as opposed to only 42.6% in 2007. The invitation coverage was highly variable, ranging from 0.2-111% for breast cancer, 7.6-105% for cervical cancer and 1.8-127% for colorectal cancer in the target populations. In spite of the considerable progress, much work remains to be done to achieve optimal effectiveness. Continued monitoring, regular feedbacks and periodic reporting are needed to ensure the desired impacts of the programmes.


European Union; breast cancer; cancer screening; cervical cancer; colorectal cancer

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center